AF Ablation With or Without ROX Coupler Study

NCT02243891 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-03-10

No results posted yet for this study

Summary

The study will test the hypothesis that ablation of paroxysmal atrial fibrillation in hypertensive subjects is more effective when a ROX coupler is inserted concurrently.

Conditions

Interventions

PROCEDURE

Atrial fibrillation ablation

Percutaneous catheter ablation for Atrial fibrillation.

PROCEDURE

ROX Coupler insertion

The ROX Coupler is a CE-marked device designed to maintain an iliac arteriovenous fistula

Sponsors & Collaborators

  • Neil Sulke

    lead OTHER

Principal Investigators

  • Neil Sulke, DM · East Sussex healthcare NHS trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-12-31
Completion
2017-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02243891 on ClinicalTrials.gov